These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 1350484

  • 1. Antihypertensive profile of carvedilol.
    Meyer-Sabellek W, Agrawal B.
    Clin Investig; 1992; 70 Suppl 1():S43-52. PubMed ID: 1350484
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure.
    Franz IW, Agrawal B, Wiewel D, Ketelhut R.
    Clin Investig; 1992 Jan; 70 Suppl 1():S53-7. PubMed ID: 1350485
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of carvedilol in hypertension: an update.
    Leonetti G, Egan CG.
    Vasc Health Risk Manag; 2012 Jan; 8():307-22. PubMed ID: 22661898
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
    Albergati F, Paternó E, Venuti RP, Boeri D, Lombardo I, Semino S, Viviani GL, Adezati L.
    J Cardiovasc Pharmacol; 1992 Jan; 19 Suppl 1():S86-9. PubMed ID: 1378156
    [Abstract] [Full Text] [Related]

  • 7. Carvedilol and the kidney.
    Dupont AG.
    Clin Investig; 1992 Jan; 70 Suppl 1():S127-31. PubMed ID: 1350479
    [Abstract] [Full Text] [Related]

  • 8. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.
    Frishman WH, Henderson LS, Lukas MA.
    Vasc Health Risk Manag; 2008 Jan; 4(6):1387-400. PubMed ID: 19337551
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T, Yoshinaga K, Kamahara Y, Ikeda M, Goto Y, Arakawa K, Iimura I, Ishii M, Kokubu T, Takeda T.
    J Cardiovasc Pharmacol; 1991 Jan; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [Abstract] [Full Text] [Related]

  • 10. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
    McPhillips JJ, Schwemer GT, Scott DI, Zinny M, Patterson D.
    Drugs; 1988 Jan; 36 Suppl 6():82-91. PubMed ID: 2908306
    [Abstract] [Full Text] [Related]

  • 11. Carvedilol.
    Crysant SG.
    Arch Fam Med; 1999 Jan; 8(4):295. PubMed ID: 10418532
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic benefits and safety of carvedilol in the treatment of renal hypertension. An open, short term study. Carvedilol Renal Hypertension Study Group in Japan.
    Kohno M, Takeda T, Ishii M, Saruta T, Mizuno Y, Yoshimura M, Kubo S, Fukiyama K, Fujishima M.
    Drugs; 1988 Jan; 36 Suppl 6():129-35. PubMed ID: 2908299
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term carvedilol therapy on renal function in essential hypertension.
    Tomita K, Marumo F.
    J Cardiovasc Pharmacol; 1992 Jan; 19 Suppl 1():S97-101. PubMed ID: 1378158
    [Abstract] [Full Text] [Related]

  • 14. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients.
    Moser M, Frishman W.
    Am J Hypertens; 1998 Jan; 11(1 Pt 2):15S-22S. PubMed ID: 9503102
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dose-effect relationship of carvedilol in essential hypertension. An open study.
    Ogihara T, Goto Y, Yoshinaga K, Kumahara Y, Iimura O, Ishii M, Murakami E, Takeda T, Kokubu T, Arakawa K.
    Drugs; 1988 Jan; 36 Suppl 6():75-81. PubMed ID: 2908305
    [Abstract] [Full Text] [Related]

  • 17. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension].
    Perocchio M, Gigli G, Barra M, Sacchetti R, Vallebona A, Rosolen GA, Orlandi S.
    Minerva Cardioangiol; 1996 Mar; 44(3):115-21. PubMed ID: 8767610
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vasodilatory action of carvedilol.
    Sponer G, Strein K, Bartsch W, Müller-Beckmann B.
    J Cardiovasc Pharmacol; 1992 Mar; 19 Suppl 1():S5-11. PubMed ID: 1378150
    [Abstract] [Full Text] [Related]

  • 20. Response rate with respect to the blood pressure-lowering effect of the vasodilating and beta-blocking agent carvedilol.
    Rittinghausen R.
    Drugs; 1988 Mar; 36 Suppl 6():92-101. PubMed ID: 2908307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.